BMJ  2005;330:644-648 (19 March), doi:10.1136/bmj.330.7492.644

Clinical review

Monitoring in chronic disease: a rational approach

¹ University of Oxford, Department of Primary Health Care, Oxford OX3 7LF UK, ² Screening and Test Evaluation Program, School of Public Health, University of Sydney, Camperdown, NSW 2006, Australia

The first 150 words of the full text of this article appear below.

Introduction

"Know which abnormality you are going to follow during treatment. Pick something you can measure." Meador C. A Little Book of Doctors' Rules. Lyons: IARC Press, 1999.

The ritual of routine visits for most chronic diseases usually includes monitoring to check on the progress or regress of the disease and the development of complications. Such checks require that we choose what to monitor, when to monitor, and how to adjust treatment. Poor choices in each can lead to poor control, poor use of time, and dangerous adjustments to treatment. For example, an audit of serum digoxin monitoring in a UK teaching hospital more than 20 years ago showed that the logic behind more than 80% of the tests requested could not be established, the timing of tests reflected poor understanding of the clinical pharmacokinetics, and about one result in four was followed by an inappropriate clinical decision.¹ Improvements are . . . [Full text of this article]

Should we monitor at all?

The phases of monitoring

Monitoring strategy

Discussion

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial

Katherine Keenan, Andrew Hayen, Bruce C Neal, and Les Irwig
BMJ 2009 338: b1492. [Abstract] [Full Text] [PDF]

Use of randomised trials to decide when to monitor response to new treatment

Katy J L Bell, Les Irwig, Jonathan C Craig, and Petra Macaskill
BMJ 2008 336: 361-365. [Extract] [Full Text] [PDF]

Charcot would have approved

Fiona Godlee
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Van Peppen, R., Schuurmans, M., Stutterheim, E., Lindeman, E., Van Meeteren, N. (2009). Promoting the use of outcome measures by an educational programme for physiotherapists in stroke rehabilitation: a pilot randomized controlled trial. Clin Rehabil 23: 1005-1017 [Abstract]  
• Keenan, K., Hayen, A., Neal, B. C, Irwig, L. (2009). Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ 338: b1492-b1492 [Abstract] [Full text]  
• Pinnock, H, Sheikh, A (2009). Primary care research and clinical practice: respiratory disease. Postgrad. Med. J. 85: 74-79 [Abstract] [Full text]  
• Bell, K. J L, Irwig, L., Craig, J. C, Macaskill, P. (2008). Use of randomised trials to decide when to monitor response to new treatment. BMJ 336: 361-365 [Full text]  
• Tennant, R., Mohammed, M. A., Coleman, J. J., Martin, U. (2007). Monitoring patients using control charts: a systematic review. Int J Qual Health Care 19: 187-194 [Abstract] [Full text]  
• van den Bemt, L., Schermer, T., van Weel, C. (2007). Rational monitoring of COPD: where do current clinical guidelines stand?. Eur Respir J 29: 1078-1081 [Full text]  
• Kuperman, G. J., Bobb, A., Payne, T. H., Avery, A. J., Gandhi, T. K., Burns, G., Classen, D. C., Bates, D. W. (2007). Medication-related Clinical Decision Support in Computerized Provider Order Entry Systems: A Review. J. Am. Med. Inform. Assoc. 14: 29-40 [Abstract] [Full text]  
• Groves, T., Wagner, E. H (2005). High quality care for people with chronic diseases. BMJ 330: 609-610 [Full text]  

Online poll

Find out more >>